The Asynchronous JavaScript and XML, usually referred to as Ajax (or AJAX, ) is a set of web development techniques that uses various web technologies on the client-side to create asynchronous web applications. With Ajax, web applications can send and retrieve data from a server asynchronously (in the background) without interfering with the display and behaviour of the existing page. By decoupling the data interchange layer from the presentation layer, Ajax allows web pages and, by extension, web applications, to change content dynamically without the need to reload the entire page. In practice, modern implementations commonly utilize JSON instead of XML. Ajax is not a technology, but rather a programming pattern. HTML and CSS can be used in combination to mark up and style information. The webpage can be modified by JavaScript to dynamically display (and allow the user to interact with) the new information. The built-in XMLHttpRequest object is used to execute Ajax on webpages, allowing websites to load content onto the screen without refreshing the page. == History == In the early-to-mid 1990s, most Websites were based on complete HTML pages. Each user action required a complete new page to be loaded from the server. This process was inefficient, as reflected by the user experience: all page content disappeared, then the new page appeared. Each time the browser reloaded a page because of a partial change, all the content had to be re-sent, even though only some of the information had changed. This placed additional load on the server and made bandwidth a limiting factor in performance. The foundations of AJAX originate back in 1996 with the introduction of JavaScript 1. Developers quickly discovered that any HTML element which accepted a "src" attribute could be used to fetch remote data. By changing the src of a hidden frame, a developer could fetch remote data, process or display it without a page refresh. The remote data could be a string, JavaScript code, XML or a partial HTML page generated on the server. The same could be done with and
Hekaton (database)
Hekaton (also known as SQL Server In-Memory OLTP) is an in-memory database for OLTP workloads built into Microsoft SQL Server. Hekaton was designed in collaboration with Microsoft Research and was released in SQL Server 2014. Traditional RDBMS systems were designed when memory resources were expensive, and were optimized for disk storage. Hekaton is instead optimized for a working set stored entirely in main memory, but is still accessible via T-SQL like normal tables. It is fundamentally different from the "DBCC PINTABLE" feature in earlier SQL Server versions. Hekaton was announced at the Professional Association for SQL Server (PASS) conference 2012.
Is an AI Art Generator Worth It in 2026?
Curious about the best AI art generator? An AI art generator is software that uses machine learning to help you get more done — it combines speed, accuracy, and an interface that just works. Hands-on testing shows real-world results vary, so a short free trial is the smartest way to decide. Whether you are a beginner or a pro, the right AI art generator slots into your workflow and pays for itself fast. Read on for hands-on impressions, pricing tiers, and the standout features that matter.
Rob Fergus
Rob Fergus is a British-American computer scientist working primarily in the fields of machine learning, deep learning, representational learning, and generative models. He is a professor of computer science at Courant Institute of Mathematical Sciences at New York University (NYU) and a research scientist at DeepMind. Fergus developed ZFNet in 2013 together with M.D. Zeiler, his PhD student in NYU. Fergus co-founded Meta AI (then known as Facebook Artificial Intelligence Research (FAIR)) along with Yann Le Cun in September 2013. In 2009, Rob Fergus co-founded the Computational Intelligence, Learning, Vision, and Robotics (CILVR) Lab at NYU along with Yann Le Cun. == Awards and recognition == Rob Fergus has been recognized in academia and received the following awards: NSF Faculty Early Career Development Program (CAREER) Sloan Research Fellowship Test-of-time awards at ECCV, CVPR and ICLR == Notable PhD students == Matt Zeiler (Clarifai founder) Wojciech Zaremba (OpenAI co-founder) Denis Yarats (Perplexity co-founder) Alex Rives (EvolutionaryScale co-founder; faculty at MIT)
AI Image Generators Reviews: What Actually Works in 2026
Trying to pick the best AI image generator? An AI image generator is software that uses machine learning to help you get more done — it scales effortlessly from a single task to thousands. The best picks balance beginner-friendly simplicity with the depth power users need, and they ship updates often. Whether you are a beginner or a pro, the right AI image generator slots into your workflow and pays for itself fast. Read on for hands-on impressions, pricing tiers, and the standout features that matter.
Imo.im
imo.im is a proprietary audio/video calling and instant messaging software service. It allows sending music, video, PDFs and other files, along with various free stickers. It supports encrypted group video and voice calls with up to 20 participants. According to its developer, the service possesses over 200 million users and over 50 million messages per day are sent through it. == History == The product was created as a web-based application in 2005 for accessing multiple chat platforms, including Facebook Messenger, Google Talk, Yahoo! Messenger, and Skype chat. It was developed by Pagebites, which is a subsidiary of Singularity IM, Inc. and required a subscriber's phone number to verify the users' account. In March 2014, support for all third-party messaging networks ended. In January 2018, the app reached 500 million installs. imo.im has implemented end-to-end encryption for its chats and calls, ensuring that the conversations remain private between the sender and receiver.
Regina Barzilay
Regina Barzilay (Hebrew: רגינה ברזילי; born 1970) is an Israeli-American computer scientist. She is a professor at the Massachusetts Institute of Technology and a faculty lead for artificial intelligence at the MIT Jameel Clinic. Her research interests are in natural language processing and applications of deep learning to chemistry and oncology. == Early life and education == Barzilay was born in Chișinău, Moldova and emigrated to Israel with her parents at the age of 20. She received bachelor's and master's degrees from Ben-Gurion University of the Negev in 1993 and 1998, respectively. She obtained a PhD in computer science from Columbia University in 2003 for research supervised by Kathleen McKeown. == Career and research == After her PhD, she spent a year as a postdoctoral researcher at Cornell University. She was appointed as Delta Electronics Professor of Electrical Engineering and Computer Science at MIT in 2016. She was diagnosed with breast cancer in 2014, which prompted her to conduct research in oncology. Barzilay won the MacArthur Fellowship in 2017. For her doctoral dissertation at Columbia University, she led the development of Newsblaster, which recognized stories from different news sources as being about the same basic subject, and then paraphrased elements from the stories to create a summary. In computational linguistics, Barzilay created algorithms that learned annotations from common languages (i.e. English) to analyze less understood languages. Prompted by her experience with breast cancer, Barzilay is applying machine learning to oncology. She is collaborating with physicians and students to devise deep learning models that utilize images, text, and structured data to identify trends that affect early diagnosis, treatment, and disease prevention. Frontline Documentary Following her battle with breast cancer in 2014, and her researching into applying artificial intelligence to improve early detection methods, she collaborated with Dr. Connie Lehman at Massachusetts General Hospital. While there Barzilay developed an AI-based system capable of predicting the likelihood of breast cancer up to five years in advance. The system leverages deep learning techniques to analyze mammograms and diagnostic notes, surpassing traditional pattern recognition by human radiologists. This breakthrough, while still in development, has the potential to significantly enhance early diagnosis and treatment outcomes. [1] Barzilay's work in this area was featured in the FRONTLINE documentary In the Age of AI, which explores the broader impact of artificial intelligence on society. === MIT Jameel Clinic === In 2018, Barzilay was appointed faculty lead for AI at the new MIT Jameel Clinic, a research center in the field of AI health sciences, including disease detection, drug discovery, and the development of medical devices. In 2020, she was part of the team—with fellow MIT Jameel Clinic faculty lead Professor James J. Collins—that announced the discovery through deep learning of halicin, the first new antibiotic compound for 30 years, which kills over 35 powerful bacteria, including antimicrobial-resistant tuberculosis, the superbug C. difficile, and two of the World Health Organization's top-three most deadly bacteria. In 2020, Collins, Barzilay and the MIT Jameel Clinic were also awarded funding through The Audacious Project to expand on the discovery of halicin in using AI to respond to the antibiotic resistance crisis through the development of new classes of antibiotics. == Awards and recognition == In 2017, Barzilay won the MacArthur Fellowship, known as the "Genius Grant", for "developing machine learning methods that enable computers to process and analyze vast amounts of human language data." She is also a recipient of various awards including the NSF Career Award, the MIT Technology Review TR-35 Award, Microsoft Faculty Fellowship and several Best Paper Awards at NAACL and ACL. Her teaching has also been recognized by MIT as she won the Jamieson Teaching Award in 2016. She was nominated an AAAI Fellow in 2018 by the Association for the Advancement of Artificial Intelligence. In 2020, she became the first recipient of the $1 million AAAI Squirrel AI Award for Artificial Intelligence for the Benefit of Humanity. In 2023, she was elected to the National Academy of Medicine and the National Academy of Engineering.